In vivo and in vitro investigation of the effects of sildenafil on rat cavernous smooth muscle

Journal of Urology

Volumn 165, Issue 3, 2001, Pages 1010-1014

  Gemalmaz, Hakan ^a,b   Waldeck, Kristian ^a,b   Chapman, Terence N ^a,b   Tuttle, Jeremy B ^a,b   Steers, William D ^a,b   Andersson, Karl Erik ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Cyclic GMP; Nitric oxide; Penile erection; Penis; Phosphodiesterase inhibitors

Indexed keywords

SILDENAFIL;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG EFFECT; ELECTROSTIMULATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RAT;

EID: 0035133532     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)66593-7     Document Type: Article

References (31)

1. Physiology of penile erection
2. Nitric oxide in the penis: Physiology and pathology
3. Erectile dysfunction in cGMP-dependent kinase I-deficient mice
4. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
5. Sildenafil: An orally active type 5 cyclic CMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
6. Sildenafil, a novel oral therapy for male erectile dysfunction
7. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro
8. Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro
9. Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue
10. The hypogastric nerve pathway to penile erectile tissue: Histochemical evidence supporting vasodilator role
11. A simplified in vitro preparation of the corpus cavernosum as a tool for investigating erectile pharmacology of the rat
12. The effects of diabetes on nitric oxide-mediated responses in rat corpus cavernosum
13. The rat as a model for the study of penile erection
14. Intracavernous pressure as an experimental index in a rat model for the evaluation of penile erection
15. NO synthase in cholinergic nerves and NO-induced relaxation in the rat isolated corpus cavernosum
16. Cyclic nucleotide phosphodiesterases and vascular smooth muscle
17. Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney
18. Die Phosphodiesterase-Isoenzyme des humanen Corpus Cavernosum Penis und deren funtionelle Bedeutung
19. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes
20. Identification of 13 phosphodiesterase isoforms in human cavernous tissue
21. Molecular biological characterization of phosphodiesterase 3A from human corpus cavernosum
22. The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo
23. Molecular biological characterisation of phosphodiesterases 3 and 5 in human corpus cavernosum penis
24. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro
25. Sildenafil, a potent selective inhibitor of type 5 phosphodiesterase enhances nitric oxide-dependent relaxation of rabbit corpus caw ernosum
26. Effects of a novel phosphodiesterase type 5 inhibitor, sildenafil, on methacholine induced relaxation of isolated rabbit corpus cavernosum
27. Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile function in the anesthetized dog
28. Nitrergic control of peripheral sympathetic responses in the human corpus cavernosum: A comparison with other species
29. Current research and future therapies
30. The effect of sildenafil on apomorphine-evoked increases in intracavernous pressure in the awake rat
31. Interactions between apomorphine and sildenafil: Evidence for normalization of erections during hyperadrenergic stimulation